D. de Kaste

1.3k total citations
30 papers, 1.1k citations indexed

About

D. de Kaste is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Economics and Econometrics. According to data from OpenAlex, D. de Kaste has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 6 papers in Pharmacology and 6 papers in Economics and Econometrics. Recurrent topics in D. de Kaste's work include Pharmaceutical Quality and Counterfeiting (15 papers), Pesticide Residue Analysis and Safety (6 papers) and Pharmaceutical Economics and Policy (6 papers). D. de Kaste is often cited by papers focused on Pharmaceutical Quality and Counterfeiting (15 papers), Pesticide Residue Analysis and Safety (6 papers) and Pharmaceutical Economics and Policy (6 papers). D. de Kaste collaborates with scholars based in Netherlands, Denmark and United States. D. de Kaste's co-authors include Bastiaan J. Venhuis, M.J. Vredenbregt, Leonore Blok‐Tip, D.M. Barends, Peter H. J. Keizers, R Hoogerbrugge, Luc Moëns, Peter Vandenabeele, Marleen De Veij and Martin Hamzink and has published in prestigious journals such as Nature, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

D. de Kaste

30 papers receiving 1000 citations

Peers

D. de Kaste

PHEOH

P. Courselle Belgium

Jacques O. De Beer Belgium

Soo-Yeul Cho South Korea

R.D. Marini Belgium

M.J. Vredenbregt Netherlands

Pierre Lebrun Belgium

KK Mueen Ahmed India

Saeed Alqahtani Saudi Arabia

Venkatesh Atul Bhattaram United States

Mohamad Mroueh Lebanon

P. Courselle Belgium

D. de Kaste

473 ×0.7

PHEOH

377 ×1.3

484 ×2.2

273 ×1.3

64 ×0.5

Citations per year, relative to D. de Kaste D. de Kaste (= 1×) peers P. Courselle

Countries citing papers authored by D. de Kaste

Since Specialization

Citations

This map shows the geographic impact of D. de Kaste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. de Kaste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. de Kaste more than expected).

Fields of papers citing papers by D. de Kaste

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. de Kaste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. de Kaste. The network helps show where D. de Kaste may publish in the future.

Co-authorship network of co-authors of D. de Kaste

This figure shows the co-authorship network connecting the top 25 collaborators of D. de Kaste. A scholar is included among the top collaborators of D. de Kaste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. de Kaste. D. de Kaste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Venhuis, Bastiaan J., et al.. (2016). Pharmacologically effective red yeast rice preparations marketed as dietary supplements illustrated by a case report. Drug Testing and Analysis. 8(3-4). 315–318. 15 indexed citations

Keizers, Peter H. J., M.J. Vredenbregt, Frank Bakker, D. de Kaste, & Bastiaan J. Venhuis. (2014). Chemical fingerprinting of silicone-based breast implants. Journal of Pharmaceutical and Biomedical Analysis. 102. 340–345. 12 indexed citations

Venhuis, Bastiaan J., et al.. (2013). Sildenafil and analogous phosphodiesterase type 5 (PDE-5) inhibitors in herbal food supplements sampled on the Dutch market. Food Additives & Contaminants Part A. 30(12). 2027–2034. 29 indexed citations

Venhuis, Bastiaan J., et al.. (2013). Dose-to-dose variations with single packages of counterfeit medicines and adulterated dietary supplements as a potential source of false negatives and inaccurate health risk assessments. Journal of Pharmaceutical and Biomedical Analysis. 89. 158–165. 32 indexed citations

Venhuis, Bastiaan J. & D. de Kaste. (2012). Scientific Opinion on the Regulatory Status of 1,3-Dimethylamylamine (DMAA). European Journal of Nutrition & Food Safety. 2(4). 93–100. 20 indexed citations

Venhuis, Bastiaan J. & D. de Kaste. (2012). Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. Journal of Pharmaceutical and Biomedical Analysis. 69. 196–208. 140 indexed citations

Venhuis, Bastiaan J., Jing Tan, M.J. Vredenbregt, et al.. (2011). Capsule shells adulterated with tadalafil. Forensic Science International. 214(1-3). e20–e22. 20 indexed citations

Venhuis, Bastiaan J., et al.. (2010). The identification of a nitrosated prodrug of the PDE-5 inhibitor aildenafil in a dietary supplement: A Viagra with a pop. Journal of Pharmaceutical and Biomedical Analysis. 54(4). 735–741. 39 indexed citations

Fransen, Heidi P., S.M.G.J. Pelgrom, Barbara Stewart‐Knox, D. de Kaste, & Hans Verhagen. (2010). Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Food & Nutrition Research. 54(1). 5221–5221. 27 indexed citations

10.

Venhuis, Bastiaan J., et al.. (2010). The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet. Journal of Pharmaceutical and Biomedical Analysis. 54(1). 21–26. 22 indexed citations

11.

Venhuis, Bastiaan J., et al.. (2009). The identification of (−)-trans-tadalafil, tadalafil, and sildenafil in counterfeit Cialis® and the optical purity of tadalafil stereoisomers. Journal of Pharmaceutical and Biomedical Analysis. 51(3). 723–727. 38 indexed citations

12.

Nauta, Maarten, et al.. (2009). Risk analysis by FMEA as an element of analytical validation. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 1085–1087. 54 indexed citations

13.

Venhuis, Bastiaan J., et al.. (2008). Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac. Journal of Pharmaceutical and Biomedical Analysis. 46(4). 814–817. 61 indexed citations

14.

Peinder, Peter de, M.J. Vredenbregt, Taco D. Visser, & D. de Kaste. (2008). Detection of Lipitor® counterfeits: A comparison of NIR and Raman spectroscopy in combination with chemometrics. Journal of Pharmaceutical and Biomedical Analysis. 47(4-5). 688–694. 67 indexed citations

15.

Venhuis, Bastiaan J., Leonore Blok‐Tip, & D. de Kaste. (2008). Designer drugs in herbal aphrodisiacs. Forensic Science International. 177(2-3). e25–e27. 31 indexed citations

16.

Veij, Marleen De, et al.. (2007). Detection of counterfeit Viagra® with Raman spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 46(2). 303–309. 93 indexed citations

17.

Vredenbregt, M.J., Leonore Blok‐Tip, R Hoogerbrugge, D.M. Barends, & D. de Kaste. (2005). Screening suspected counterfeit Viagra® and imitations of Viagra® with near-infrared spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 40(4). 840–849. 100 indexed citations

18.

Blok‐Tip, Leonore, et al.. (2003). Analysis of optically active compounds using conventional chromatography with a circular dichroism detector. Journal of Pharmaceutical and Biomedical Analysis. 32(4-5). 905–912. 11 indexed citations

19.

Kaste, D. de, et al.. (2002). An improved in vitro method for the evaluation of antacids with in vivo relevance. European Journal of Pharmaceutics and Biopharmaceutics. 53(2). 217–225. 4 indexed citations

20.

Kaste, D. de, et al.. (1996). Pharmaceutical analysis of the oral iron chelator deferiprone (DMHP, L1). Pharmacy World & Science. 18(4). 142–147. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact